Article Details

Atezolizumab by F. Hoffmann-La Roche for Colorectal Cancer: Likelihood of Approval

Retrieved on: 2023-12-25 18:21:40

Tags for this article:

Click the tags to see associated articles and topics

Atezolizumab by F. Hoffmann-La Roche for Colorectal Cancer: Likelihood of Approval. View article details on HISWAI: https://www.pharmaceutical-technology.com/data-insights/atezolizumab-f-hoffmann-la-roche-colorectal-cancer-likelihood-of-approval/

Excerpt

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Colorectal Cancer.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up